Gina Segovia-Siapco1, Peter Pribis2, Keiji Oda3, Joan Sabaté3. 1. Center for Nutrition, Healthy Lifestyle, & Disease Prevention, School of Public Health, Loma Linda University, 24951 North Circle Drive, Loma Linda, CA 92350, USA. gsiapco@llu.edu. 2. Department of Individual, Family & Community Education, College of Education, University of New Mexico, Hokona Hall 157 MSC05 3040, Albuquerque, NM 87131-0001, USA. 3. Center for Nutrition, Healthy Lifestyle, & Disease Prevention, School of Public Health, Loma Linda University, 24951 North Circle Drive, Loma Linda, CA 92350, USA.
Abstract
PURPOSE: Isoflavones have estrogenic properties that may adversely affect pubertal development of boys. We examined if soy isoflavone consumption is associated with age at pubarche (first onset of pubic hair) in a male population with a wide range of soy intake. METHODS: Boys aged 12-18 years (n = 248) who attended schools around Adventist universities in Southern California and Michigan self-reported their age at pubarche. Intake of soy isoflavones was assessed using a validated Web-based food frequency questionnaire; consumption levels were designated as low, moderate, and high. Descriptives, time-to-event analysis, and Cox proportional hazards regression that controlled for confounders were performed. RESULTS: Energy-adjusted mean intakes were 0.8-54.9 mg/d for total isoflavones, 0.4-22.1 mg/d for daidzein, and 0.4-28.0 mg/d for genistein. Moderate and high total soy isoflavone intake were significantly associated with earlier adjusted median age at pubarche: 12.58 years [RR (95% CI): 1.58 (1.06, 2.36)] for moderate and 12.50 years [RR (95% CI): 1.63 (1.03, 2.60)] for high vs. 13.00 years for low consumers. Similarly, daidzein and genistein consumption was also significantly associated with age at pubarche. No significant associations were found for facial hair for any of the isoflavones. CONCLUSIONS: Age at pubarche in this male population widely exposed to soy is within the reported range for boys' pubarcheal age; moderate/high consumers tend to have it earlier compared to low consumers. Further studies are needed to ascertain that substantial exposure to soy isoflavones does not adversely affect pubertal development of boys.
PURPOSE:Isoflavones have estrogenic properties that may adversely affect pubertal development of boys. We examined if soy isoflavone consumption is associated with age at pubarche (first onset of pubic hair) in a male population with a wide range of soy intake. METHODS:Boys aged 12-18 years (n = 248) who attended schools around Adventist universities in Southern California and Michigan self-reported their age at pubarche. Intake of soy isoflavones was assessed using a validated Web-based food frequency questionnaire; consumption levels were designated as low, moderate, and high. Descriptives, time-to-event analysis, and Cox proportional hazards regression that controlled for confounders were performed. RESULTS: Energy-adjusted mean intakes were 0.8-54.9 mg/d for total isoflavones, 0.4-22.1 mg/d for daidzein, and 0.4-28.0 mg/d for genistein. Moderate and high total soy isoflavone intake were significantly associated with earlier adjusted median age at pubarche: 12.58 years [RR (95% CI): 1.58 (1.06, 2.36)] for moderate and 12.50 years [RR (95% CI): 1.63 (1.03, 2.60)] for high vs. 13.00 years for low consumers. Similarly, daidzein and genistein consumption was also significantly associated with age at pubarche. No significant associations were found for facial hair for any of the isoflavones. CONCLUSIONS: Age at pubarche in this male population widely exposed to soy is within the reported range for boys' pubarcheal age; moderate/high consumers tend to have it earlier compared to low consumers. Further studies are needed to ascertain that substantial exposure to soy isoflavones does not adversely affect pubertal development of boys.
Authors: Adam M Karpati; Carol H Rubin; Stephanie M Kieszak; Michele Marcus; Richard P Troiano Journal: J Adolesc Health Date: 2002-03 Impact factor: 5.012
Authors: M Tanaka; K Fujimoto; Y Chihara; K Torimoto; T Yoneda; N Tanaka; A Hirayama; N Miyanaga; H Akaza; Y Hirao Journal: Prostate Cancer Prostatic Dis Date: 2009-07-14 Impact factor: 5.554
Authors: Julia A Graber; John R Seeley; Jeanne Brooks-Gunn; Peter M Lewinsohn Journal: J Am Acad Child Adolesc Psychiatry Date: 2004-06 Impact factor: 8.829
Authors: Jingyuan Xiong; Yujie Xu; Xueting Liu; Xiaoyu Wang; Shufang Shan; M James C Crabbe; Li Zhao; He Fang; Guo Cheng Journal: BMC Med Date: 2022-04-04 Impact factor: 8.775
Authors: João Soares Felício; Angélica Leite de Alcântara; Luísa Corrêa Janaú; Lorena Vilhena de Moraes; Maria Clara Neres Iunes de Oliveira; Manuela Nascimento de Lemos; Norberto Jorge Kzan de Souza Neto; João Felício Abrahão Neto; Wanderson Maia da Silva; Ícaro José Araújo de Souza; Nivin Mazen Said; Gabriela Nascimento de Lemos; Giovana Miranda Vieira; André Salim Khayat; Ândrea Kely Campos Ribeiro Dos Santos; Natércia Neves Marques de Queiroz; Ana Carolina Contente Braga de Sousa; Márcia Costa Dos Santos; Franciane Trindade Cunha de Melo; Pedro Paulo Freire Piani; Karem Miléo Felício Journal: Front Endocrinol (Lausanne) Date: 2021-07-05 Impact factor: 5.555